99 related articles for article (PubMed ID: 20226854)
21. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
22. RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis.
Dehn DL; Inayat-Hussain SH; Ross D
J Pharmacol Exp Ther; 2005 May; 313(2):771-9. PubMed ID: 15665137
[TBL] [Abstract][Full Text] [Related]
23. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
[TBL] [Abstract][Full Text] [Related]
24. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ.
Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N
Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
26. Role of the common γ chain in cell cycle progression of human malignant cell lines.
Vigliano I; Palamaro L; Bianchino G; Fusco A; Vitiello L; Grieco V; Romano R; Salvatore M; Pignata C
Int Immunol; 2012 Mar; 24(3):159-67. PubMed ID: 22223761
[TBL] [Abstract][Full Text] [Related]
27. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1.
Moscovitz O; Tsvetkov P; Hazan N; Michaelevski I; Keisar H; Ben-Nissan G; Shaul Y; Sharon M
Mol Cell; 2012 Jul; 47(1):76-86. PubMed ID: 22793692
[TBL] [Abstract][Full Text] [Related]
28. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.
Foppoli C; De Marco F; Blarzino C; Perluigi M; Cini C; Coccia R
Int J Biochem Cell Biol; 2005 Apr; 37(4):852-63. PubMed ID: 15694844
[TBL] [Abstract][Full Text] [Related]
29. NADPH:quinone oxidoreductase-1 as a new regulatory enzyme that increases melanin synthesis.
Yamaguchi Y; Hearing VJ; Maeda A; Morita A
J Invest Dermatol; 2010 Mar; 130(3):645-7. PubMed ID: 20145642
[TBL] [Abstract][Full Text] [Related]
30. NQO1 regulates cell cycle progression at the G2/M phase.
Oh ET; Kim HG; Kim CH; Lee J; Kim C; Lee JS; Cho Y; Park HJ
Theranostics; 2023; 13(3):873-895. PubMed ID: 36793872
[No Abstract] [Full Text] [Related]
31. NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines.
Bruge F; Virgili S; Cacciamani T; Principi F; Tiano L; Littarru GP
Biofactors; 2008; 32(1-4):71-81. PubMed ID: 19096102
[TBL] [Abstract][Full Text] [Related]
32. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and genetic analysis of NAD(P)H:quinone oxidoreductase 1 (NQO1).
Siegel D; Kepa JK; Ross D
Curr Protoc Toxicol; 2007; Chapter 4():Unit4.22. PubMed ID: 23045144
[TBL] [Abstract][Full Text] [Related]
34. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines.
Fischer TW; Zmijewski MA; Zbytek B; Sweatman TW; Slominski RM; Wortsman J; Slominski A
Int J Oncol; 2006 Sep; 29(3):665-72. PubMed ID: 16865283
[TBL] [Abstract][Full Text] [Related]
35. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.
Patrick BA; Gong X; Jaiswal AK
Oncogene; 2011 Mar; 30(9):1098-107. PubMed ID: 21042282
[TBL] [Abstract][Full Text] [Related]
36. DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
Cabello CM; Lamore SD; Bair WB; Davis AL; Azimian SM; Wondrak GT
Free Radic Res; 2011 Mar; 45(3):276-92. PubMed ID: 21034357
[TBL] [Abstract][Full Text] [Related]
37. Redox modulation of NQO1.
Siegel D; Dehn DD; Bokatzian SS; Quinn K; Backos DS; Di Francesco A; Bernier M; Reisdorph N; de Cabo R; Ross D
PLoS One; 2018; 13(1):e0190717. PubMed ID: 29298345
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro evaluation of radioiodinated indolequinones targeting NAD(P)H: quinone oxidoreductase 1 for internal radiation therapy.
Sasaki J; Sano K; Hagimori M; Yoshikawa M; Maeda M; Mukai T
Bioorg Med Chem; 2014 Nov; 22(21):6039-46. PubMed ID: 25281270
[TBL] [Abstract][Full Text] [Related]
39. NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associated with prostate tumorigenesis.
Thapa D; Meng P; Bedolla RG; Reddick RL; Kumar AP; Ghosh R
Cancer Res; 2014 Oct; 74(19):5644-55. PubMed ID: 25125658
[TBL] [Abstract][Full Text] [Related]
40. ATP independent proteasomal degradation of NQO1 in BL cell lines.
Scarpa ES; Bonfili L; Eleuteri AM; La Teana A; Brugè F; Bertoli E; Littarru GP; Cacciamani T
Biochimie; 2012 May; 94(5):1242-9. PubMed ID: 22586705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
